A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous non-small cell lung cancer (sqNSCLC) previously treated with platinum-based chemotherapy.Giorgio V. Scagliotti, Ramaswamy Govindan, Igor Bondarenko et al.|Journal of Clinical Oncology|2018Cited by 10
Abstract PS7-03: A first-in-human phase 1a/b trial of LOXO-783, a potent, highly mutant-selective, brain-penetrant, allosteric PI3Kα H1047R inhibitor in PIK3CA H1047R-mutant advanced breast cancer and other solid tumors: Results from the PIKASSO-01 studyKomal Jhaveri, Funda Meric-Bernstam, X. Cynthia et al.|Clinical Cancer Research|2025Cited by 2